Drug Trial Radar · NCT03394612
Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Full-Thickness Skin Defects in Adults and Children
Last checked: Nov 19, 2026Latest source record: Aug 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
21
Actual
Start
Feb 14, 2018
Primary completion
Dec 1, 2023
Study completion Aug 21, 2026
Sponsor
- Lead sponsor
- CUTISS AGIndustry
- Sponsor type
- Industry
- Collaborators
- Wyss Zurich; Julius Clinical; Sintesi Research Srl; University Hospital, Zürich; University of Zurich
- First posted
- Jan 9, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 1 year
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase II trial aims to evaluate the efficacy and safety of EHSG-KF (synonym denovoSkin) in comparison to meshed STSG in adults and children with full-thickness Skin defects.
Conditions
- Skin Wound
Interventions
EHSG-KFBiological
Transplantation of autologous dermo-epidermal skin substitute EHSG-KF to the experimental area
STSGBiological
Transplantation of autologous split-thickness skin graft to the control area
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy of EHSG-KF in comparison to STSG based on the assessment of scar qualityTime frame: 3 months post grafting
Locations
7 sites in 3 countries. Site status is shown where the registry gives one.
Chirurgia Plastica e Centro Ustioni Azienda Ospedaliera di Rilievo Nazionale A. Cardarelli
Naples, Italy
Unità di Chirurgia Plastica e Ustioni Ospedale Santobono
Naples, Italy
U.O.C. Grandi Ustionati Azienda Ospedale Università Padova
Padova, Italy
Dept. of Plastic, Reconstructive and Hand Surgery, VU University Medical Center
Amsterdam, Netherlands
Rode Kruis Ziekenhuis
Beverwijk, Netherlands
University Children's Hospital Zurich
Zurich, Switzerland
University Hospital Zurich
Zurich, Switzerland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.